US 11753369
Creatine prodrugs, compositions and methods of use thereof
granted A61KA61K45/06
Quick answer
US patent 11753369 (Creatine prodrugs, compositions and methods of use thereof) held by Ultragenyx Pharmaceutical Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K45/06